Paper39100738
Oropouche virus presenting in Italy after travel to Cuba.
Branda F and 2 others. New Microbes New Infect, 2024. Cited by 6 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Oropouche virus presenting in Italy after travel to Cuba. Papers, record 39100738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39100738
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References5
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29,247,710 | Oropouche fever, an emergent disease from the Americas. | Microbes Infect | 2018 | https://conductscience.org/library/papers/29247710 | PubMed |
| 2 | 38,281,494 | Emergence of Oropouche fever in Latin America: a narrative review. | Lancet Infect Dis | 2024 | https://conductscience.org/library/papers/38281494 | PubMed |
| 3 | 16,699,043 | Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa. | J Virol | 2006 | https://conductscience.org/library/papers/16699043 | PubMed |
| 4 | 6,782,898 | Oropouche virus. I. A review of clinical, epidemiological, and ecological findings. | Am J Trop Med Hyg | 1981 | https://conductscience.org/library/papers/6782898 | PubMed |
| 5 | 38,224,842 | Oropouche virus: A neglected global arboviral threat. | Virus Res | 2024 | https://conductscience.org/library/papers/38224842 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,377,455 | The emerging threat of Oropouche virus in Latin America: epidemiology, clinical manifestations, diagnosis, and management. | Ann Med Surg (Lond) | 2025 | https://conductscience.org/library/papers/41377455 | PubMed |
| 41,343,261 | Mapping evolutionary paradigm of Oropouche virus driven by dinucleotide bias and context-dependent codon bias. | Virulence | 2025 | https://conductscience.org/library/papers/41343261 | PubMed |
| 40,510,237 | Re-emergence of Oropouche virus as a novel global threat. | Curr Res Microb Sci | 2025 | https://conductscience.org/library/papers/40510237 | PubMed |
| 40,491,501 | The emergence of oropouche fever: A potential new threat? | New Microbes New Infect | 2025 | https://conductscience.org/library/papers/40491501 | PubMed |
| 39,262,674 | Oropouche fever rears its head in Cuba: What lies beneath the surface? | New Microbes New Infect | 2024 | https://conductscience.org/library/papers/39262674 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39100738
GET https://conductscience.org/api/papers/v1/39100738/authors